Home > Reports, Tools, & Publications > Resident-Level Predictors of Dementia Pharmacotherapy at Long-Term Care Admission: The Impact of Different Drug Reimbursement Policies in Ontario and Saskatchewan

Resident-Level Predictors of Dementia Pharmacotherapy at Long-Term Care Admission: The Impact of Different Drug Reimbursement Policies in Ontario and Saskatchewan

journal article hqc
Laura C. Maclagan, Susan E. Bronskill, Michael A. Campitelli, Shenzhen Yao, Christoffer Dharma, David B. Hogan, Nathan Hermann, Joseph E. Amuah, Colleen J. Maxwell
The Canadian Journal of Psychiatry
April 10, 2020

The publication aims to compare resident-level characteristics associated with dementia pharmacotherapy at long-term care admission in facilities in Saskatchewan and Ontario.

Citation

Maclagan LC, Bronskill SE, Campitelli MA, et al. Resident-Level Predictors of Dementia Pharmacotherapy at Long-Term Care Admission: The Impact of Different Drug Reimbursement Policies in Ontario and Saskatchewan: Prédicteurs de la pharmacothérapie de la démence au niveau des résidents lors de l’hospitalisation dans des soins de longue durée : l’impact de différentes politiques de remboursement des médicaments en Ontario et en Saskatchewan. The Canadian Journal of Psychiatry. 2020;65(11):790-801. doi:10.1177/0706743720909293

https://doi.org/10.1177/0706743720909293